查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609554

組織診斷市場規模、佔有率、趨勢分析報告：2025-2030 年按技術、應用、最終用途、地區和細分市場進行的預測

Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology, By Application, By Modality, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 171 Pages | 商品交期: 2-10個工作天內

價格

組織診斷市場成長與趨勢

根據Grand View Research, Inc最新報告，預計到2030年，全球組織診斷市場規模將達到140.3億美元，2025年至2030年複合年成長率為8.41%。

由於缺乏熟練的病理學家，對自動化組織診斷系統的需求不斷增加，正在推動組織診斷產業的發展。螢光等先進成像技術的出現最大限度地減少了對侵入性診斷的需求，進一步促進了市場的成長。

近年來，由於數位幻燈片的軟質放大和遠端存取幻燈片等相關優勢，其使用顯著增加。在越來越重視精準醫療的美國，多個組織和公司正在支持這一點，預計這將有助於市場成長。此外，公司也透過新穎的腫瘤學解決方案支持精準醫療的發展。例如，2020 年 5 月，QIAGEN 發布了新的腫瘤學解決方案，例如腫瘤基因組分析軟體解決方案 QCI Interpret One。成像技術的進步預計將對市場成長產生積極影響。

此外，組織診斷行業的新興趨勢之一是數位病理學與人工智慧（AI）的融合。數位病理學掃描組織切片並將數位化，使病理學家能夠遠端查看和分析影像。然後，人工智慧演算法可以應用於這些數位影像，以幫助解釋和分析組織樣本。這種整合可以實現更快、更準確的診斷，提高工作流程效率並改善患者護理。它還促進了預測模型和精準醫學方法的開發。因此，市場對數位病理解決方案和人工智慧主導的組織診斷平台的需求不斷成長。

診斷影像技術的進步也提高了乳癌檢測和診斷的敏感度。例如，2023 年 5 月，BPGbio 最近宣布與國防部 (DoD) 達成協議，重點關注人工智慧驅動的乳癌診斷。利用人工智慧創建的新小組旨在檢測被診斷為 ER+ 乳癌且對荷爾蒙療法無反應的女性，從而提供更好的替代治療並提高治療效果。

BPGbio 獨特的 34 基因乳癌診斷面板專注於數量顯著增加的 ER+ 乳癌，並將透過 Interrogative Biology Platform 進行更廣泛的評估。乳腺組織分析的技術擴展包括使用數位方法、斷層合成、CAD 等進行基因表現、細胞生物化學和分子生物學評估的程序。

組織診斷市場報告亮點

  • 免疫組化細分市場將在 2024 年以 25.79% 的收益佔有率佔據市場主導地位。免疫組織化學 (IHC) 是一種專門的染色測試，可將診斷抗體與細胞膜和含有組織樣本的玻片上的細胞上存在的特定目標蛋白結合。
  • 數位病理學和工作流程領域預計將以 12.22% 的複合年成長率成長最快。數位病理學和工作流程整合透過增強成像、資料管理和分析，徹底改變了 ISH 應用。
  • 預計到2024年乳癌細分市場將佔據最大市場佔有率，達到50.45%，並且複合年成長率最快。由於生活方式的改變和世界人口的迅速老化，乳癌發病率不斷增加，為這一領域提供了利潤豐厚的成長機會。
  • 預計臨床細分市場將在 2024 年佔據市場主導地位，並在預測期內以 8.83% 的複合年成長率成長最快。
  • 2024 年，醫院將佔據最大的銷售額佔有率，達到 37.82%。醫院和診所對組織診斷系統和服務的使用逐年增加。在一些醫院和診所，醫生正在從傳統的檢測方法轉向組織診斷檢測。
  • 2024年北美組織診斷市場佔比44.76%。這是由於癌症和其他疾病的盛行率不斷增加，對先進診斷工具的需求不斷增加。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 工業分析工具
    • 波特五力分析
    • PESTEL分析

第4章科技業務分析

  • 組織診斷市場：技術變革分析
  • 免疫組織化學
    • 免疫組織化學市場，2018-2030
    • 裝置
    • 消耗品
  • 原位雜合反應
    • 原位雜合反應市場，2018-2030
    • 裝置
    • 消耗品
    • 軟體
  • 初級染色和特殊染色
    • 2018-2030年初級染色及特殊染色市場
  • 數位病理學和工作流程
    • 數位病理學和工作流程市場，2018-2030
    • 影像分析資訊學
    • 資訊管理系統儲存與通訊
  • 解剖病理學
    • 解剖病理學市場，2018-2030
    • 裝置
    • 消耗品
  • 分子病理學
    • 分子病理學市場，2018-2030
    • 裝置
    • 試劑
    • 其他

第5章 應用業務分析

  • 組織診斷市場：應用變化分析
  • 乳癌
    • 乳癌市場，2018-2030
  • 非小細胞肺癌
    • 非小細胞肺癌市場，2018-2030
  • 攝護腺癌
    • 攝護腺癌市場，2018-2030
  • 胃癌
    • 2018-2030年胃癌市場
  • 其他癌症
    • 其他癌症市場，2018-2030

第6章 模態業務分析

  • 組織診斷市場：模態變異分析
  • 臨床
    • 臨床市場，2018-2030
  • 製藥/CRO/研究市場
    • 製藥/CRO/研究市場，2018-2030

第7章 最終用途業務分析

  • 醫院
    • 醫院市場，2018-2030
  • 診斷中心
    • 診斷中心市場，2018-2030
  • 製藥組織
    • 2018-2030年醫用紙巾市場
  • CRO
    • CRO市場，2018-2030

第8章區域業務分析

  • 2024 年及 2030 年組織診斷市場佔有率（按地區）
  • 北美洲
    • SWOT分析
    • 北美組織診斷市場，2018-2030
    • 美國
    • 墨西哥
    • 加拿大
  • 歐洲
    • SWOT分析
    • 歐洲組織診斷市場，2018-2030
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 亞太組織診斷市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲組織診斷市場，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • SWOT分析
    • 中東和非洲組織診斷市場，2018-2030
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 科威特

第9章 競爭格局

  • 公司分類
  • 策略規劃
  • 2022 年企業市場佔有率分析
  • 公司簡介/上市公司
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Thermo Fisher Scientific, Inc.
    • Siemens
    • Danaher Corporation
    • bioMerieux SA
    • QIAGEN
    • BD
    • Merck KGaA
    • GE Healthcare
    • BioGenex
    • Cell Signaling Technology, Inc.
    • Bio SB
    • DiaGenic ASA
    • Agilent Technologies, Inc
Product Code: 978-1-68038-399-7

Tissue Diagnostics Market Growth & Trends:

The global tissue diagnostics market size is expected to reach USD 14.03 billion by 2030, registering a CAGR of 8.41% from 2025 to 2030, according to a new report by Grand View Research, Inc. Accelerating demand for automated tissue diagnostic systems due to a lack of skilled pathologists has driven the tissue diagnostics industry. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplements the market growth.

The use of digital slides has significantly increased in recent years, owing to its associated benefits including flexible magnification and remote access to slides. The growing emphasis on precision medicine is supported by several organizations & companies in the U.S., which is expected to contribute to the market growth. Additionally, companies are supporting the development of precision medicine with novel oncology solutions. For instance, in May 2020, QIAGEN launched new oncology solutions, such as the QCI Interpret One software solution for genomic profiling of tumors. The advancements in imaging techniques are expected to positively influence market growth.

In addition, one of the emerging trends in the tissue diagnostics industry is the integration of digital pathology and artificial intelligence (AI). Digital pathology involves the scanning and digitization of tissue slides, allowing pathologists to review and analyze images remotely. AI algorithms can then be applied to these digital images to aid in the interpretation and analysis of tissue samples. This integration enables faster and more accurate diagnoses, enhances workflow efficiency, and improves patient care. It also facilitates the development of predictive models and precision medicine approaches. As a result, there is a growing demand for digital pathology solutions and AI-driven tissue diagnostics platforms in the market.

With technological improvements in imaging techniques, the sensitivity of detection and diagnosis of breast cancer has also improved. For instance, in May 2023, with an emphasis on AI-guided breast cancer diagnoses, BPGbio recently announced an agreement with the Department of Defense (DoD). The new panel, created with artificial intelligence, is intended to detect women diagnosed with ER+ breast cancer but do not react to hormone therapy, allowing for more suitable treatment alternatives and improving treatment response.

The unique 34-gene breast cancer diagnostic panel from BPGbio will also receive wider evaluation through the Interrogative Biology Platform, focusing on ER+ breast cancers, which are significantly rising. Technological expansion in breast tissue analysis includes procedures for evaluating gene expression, cellular biochemistry, and molecular biology using digital methods, tomosynthesis, CAD, and other methods.

Tissue Diagnostics Market Report Highlights:

  • The immunohistochemistry segment dominated the market in terms of revenue share of 25.79% in 2024. Immunohistochemistry (IHC) is a special staining test in which a diagnostic antibody is bound to a specific target protein present in cell membranes or cells on slides containing tissue samples.
  • The digital pathology and workflow segment is anticipated to grow at the fastest CAGR of 12.22%. Digital pathology and workflow integration have revolutionized the application of ISH by enhancing imaging, data management, and analysis.
  • The breast cancer segment held the largest market share of 50.45% in 2024 and is anticipated to grow at the fastest CAGR. The increasing incidence of breast cancer due to lifestyle changes and rapidly aging global population provide lucrative growth opportunities for the segment.
  • The clinical market segment dominated the market in 2024 and is anticipated to grow at the fastest CAGR of 8.83% over the forecast period, driven by advancements in medical technology, increasing disease prevalence, and a rising demand for precise & personalized medicine.
  • The hospitals dominated the market with the largest revenue share of 37.82% in 2024. The usage of tissue diagnostic systems and services in hospitals & clinics has increased over the years. In several hospitals and clinics, physicians are switching to tissue diagnostic tests from conventional testing procedures.
  • North America tissue diagnostics market accounted for a 44.76% share in 2024, driven by a rising demand for advanced diagnostic tools due to the increasing prevalence of cancer and other diseases.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Application Segment
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Modality Segment
      • 1.1.1.4. End use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
    • 1.3.1. Objectives
    • 1.3.2. Objective - 1
    • 1.3.3. Objective - 2
    • 1.3.4. Objective - 3
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information or Data Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Technology & Application Snapshot
  • 2.3. Modality & End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Worldwide increase in cancer prevalence
      • 3.2.1.2. Advancements in imaging techniques and increasing affordability of diagnostics
      • 3.2.1.3. Growth of personalized therapeutics and diagnostics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High costs associated with R&D and clinical trials
      • 3.2.2.2. Presence of non-valued based reimbursement policy
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Tissue Diagnostics Market: Technology Movement Analysis
  • 4.2. Immunohistochemistry
    • 4.2.1. Immunohistochemistry Market, 2018 - 2030 (USD Million)
    • 4.2.2. Instruments
      • 4.2.2.1. Instruments Market, 2018 - 2030 (USD Million)
      • 4.2.2.2. Slide Staining Systems
        • 4.2.2.2.1. Slide Staining Systems Market, 2018 - 2030 (USD Million)
      • 4.2.2.3. Tissue Microarrays
        • 4.2.2.3.1. Tissue Microarrays Market, 2018 - 2030 (USD Million)
      • 4.2.2.4. Tissue Processing Systems
        • 4.2.2.4.1. Tissue Processing Systems Market, 2018 - 2030 (USD Million)
      • 4.2.2.5. Slide Scanners
        • 4.2.2.5.1. Slide Scanners Market, 2018 - 2030 (USD Million)
      • 4.2.2.6. Cell Processors
        • 4.2.2.6.1. Cell Processors Market, 2018 - 2030 (USD Million)
      • 4.2.2.7. Microtomes
        • 4.2.2.7.1. Microtomes Market, 2018 - 2030 (USD Million)
      • 4.2.2.8. Embedding Systems
        • 4.2.2.8.1. Embedding Systems Market, 2018 - 2030 (USD Million)
      • 4.2.2.9. Cover Slippers
        • 4.2.2.9.1. Cover Slippers Market, 2018 - 2030 (USD Million)
      • 4.2.2.10. Other Products
        • 4.2.2.10.1. Other Products Market, 2018 - 2030 (USD Million)
    • 4.2.3. Consumables
      • 4.2.3.1. Consumables Market, 2018 - 2030 (USD Million)
      • 4.2.3.2. H&E stainer coverslipper
        • 4.2.3.2.1. H&E stainer coverslipper Market, 2018 - 2030 (USD Million)
      • 4.2.3.3. IHC stainer coverslipper
        • 4.2.3.3.1. IHC stainer coverslipper Market, 2018 - 2030 (USD Million)
      • 4.2.3.4. Antibodies
        • 4.2.3.4.1. Antibodies Market, 2018 - 2030 (USD Million)
      • 4.2.3.5. Others
        • 4.2.3.5.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. In situ Hybridization
    • 4.3.1. In situ Hybridization Market, 2018 - 2030 (USD Million)
    • 4.3.2. Instruments
      • 4.3.2.1. Instruments Market, 2018 - 2030 (USD Million)
      • 4.3.2.2. Stainers
        • 4.3.2.2.1. Stainers Market, 2018 - 2030 (USD Million)
      • 4.3.2.3. Others
        • 4.3.2.3.1. Others Market, 2018 - 2030 (USD Million)
    • 4.3.3. Consumables
      • 4.3.3.1. Consumables Market, 2018 - 2030 (USD Million)
    • 4.3.4. Software
      • 4.3.4.1. Software Market, 2018 - 2030 (USD Million)
  • 4.4. Primary & Special Staining
    • 4.4.1. Primary & Special Staining Market, 2018 - 2030 (USD Million)
  • 4.5. Digital Pathology & Workflow
    • 4.5.1. Digital Pathology & Workflow Market, 2018 - 2030 (USD Million)
    • 4.5.2. Image Analysis Informatics
      • 4.5.2.1. Image Analysis Informatics Market, 2018 - 2030 (USD Million)
    • 4.5.3. Information Management System Storage & Communication
      • 4.5.3.1. Information Management System Storage & Communication Market, 2018 - 2030 (USD Million)
  • 4.6. Anatomic Pathology
    • 4.6.1. Anatomic Pathology Market, 2018 - 2030 (USD Million)
    • 4.6.2. Instruments
      • 4.6.2.1. Instruments Market, 2018 - 2030 (USD Million)
      • 4.6.2.2. Microtomes & Cryostat Microtomes
        • 4.6.2.2.1. Microtomes & Cryostat Microtomes Market, 2018 - 2030 (USD Million)
      • 4.6.2.3. Tissue Processors
        • 4.6.2.3.1. Tissue Processors Market, 2018 - 2030 (USD Million)
      • 4.6.2.4. Automatic Strainers
        • 4.6.2.4.1. Automatic Strainers Market, 2018 - 2030 (USD Million)
      • 4.6.2.5. Other Products
        • 4.6.2.5.1. Other Products Market, 2018 - 2030 (USD Million)
    • 4.6.3. Consumables
      • 4.6.3.1. Consumables Market, 2018 - 2030 (USD Million)
      • 4.6.3.2. Antibodies & Reagents
        • 4.6.3.2.1. Antibodies & Reagents Market, 2018 - 2030 (USD Million)
      • 4.6.3.3. Probes & Kits
        • 4.6.3.3.1. Probes & Kits Market, 2018 - 2030 (USD Million)
      • 4.6.3.4. Others
        • 4.6.3.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.7. Molecular Pathology
    • 4.7.1. Anatomic Pathology Market, 2018 - 2030 (USD Million)
    • 4.7.2. Instruments
      • 4.7.2.1. Instruments Market, 2018 - 2030 (USD Million)
    • 4.7.3. Reagents
      • 4.7.3.1. Reagents Market, 2018 - 2030 (USD Million)
      • 4.7.3.2. Fluorescence Reagents
        • 4.7.3.2.1. Fluorescence Reagents Market, 2018 - 2030 (USD Million)
      • 4.7.3.3. Others
        • 4.7.3.3.1. Others Market, 2018 - 2030 (USD Million)
    • 4.7.4. Others
      • 4.7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Tissue Diagnostics Market: Application Movement Analysis
  • 5.2. Breast Cancer
    • 5.2.1. Breast Cancer Market, 2018 - 2030 (USD Million)
  • 5.3. Non-Small Cell Lung Cancer
    • 5.3.1. Non-Small Cell Lung Cancer Market, 2018 - 2030 (USD Million)
  • 5.4. Prostate Cancer
    • 5.4.1. Prostate Cancer Market, 2018 - 2030 (USD Million)
  • 5.5. Gastric Cancer
    • 5.5.1. Gastric Cancer Market, 2018 - 2030 (USD Million)
  • 5.6. Other Cancers
    • 5.6.1. Other Cancers Technology Market, 2018 - 2030 (USD Million)

Chapter 6. Modality Business Analysis

  • 6.1. Tissue Diagnostics Market: Modality Movement Analysis
  • 6.2. Clinical
    • 6.2.1. Clinical Market, 2018 - 2030 (USD Million)
  • 6.3. Pharma / CRO / Research market
    • 6.3.1. Pharma / CRO / Research Market, 2018 - 2030 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Hospitals
    • 7.1.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 7.2. Diagnostic Center
    • 7.2.1. Diagnostic Center Market, 2018 - 2030 (USD Million)
  • 7.3. Pharmaceutical Organizations
    • 7.3.1. Pharmaceutical Organizations Market, 2018 - 2030 (USD Million)
  • 7.4. CRO
    • 7.4.1. CRO Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Tissue Diagnostics Market Share By Region, 2024 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. U.S. Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Mexico Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.2.5. Canada
      • 8.2.5.1. Key Country Dynamics
      • 8.2.5.2. Target Disease Prevalence
      • 8.2.5.3. Competitive Scenario
      • 8.2.5.4. Regulatory Framework
      • 8.2.5.5. Canada Tissue Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. UK Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Germany Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.5. Spain
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Spain Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.6. France
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. France Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.7. Italy
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Italy Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Denmark Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Sweden Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Target Disease Prevalence
      • 8.3.10.3. Competitive Scenario
      • 8.3.10.4. Regulatory Framework
      • 8.3.10.5. Norway Tissue Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Japan Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. China Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. India Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. South Korea Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.7. Australia
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Australia Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.8. Thailand
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. Thailand Tissue Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Brazil Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Argentina Tissue Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. South Africa Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. UAE Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.5. Saudi Arabia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Saudi Arabia Tissue Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Regulatory Framework
      • 8.6.6.5. Kuwait Tissue Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2022
  • 9.4. Company Profiles/Listing
    • 9.4.1. F. Hoffmann-La Roche Ltd.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Technology Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Abbott Laboratories
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Technology Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Thermo Fisher Scientific, Inc.
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Technology Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Siemens
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Technology Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Danaher Corporation
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Technology Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. bioMerieux SA
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Technology Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. QIAGEN
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Technology Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. BD
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Technology Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Merck KGaA
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Technology Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. GE Healthcare
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Technology Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. BioGenex
      • 9.4.11.1. Overview
      • 9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.11.3. Technology Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Cell Signaling Technology, Inc.
      • 9.4.12.1. Overview
      • 9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.12.3. Technology Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. Bio SB
      • 9.4.13.1. Overview
      • 9.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.13.3. Technology Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. DiaGenic ASA
      • 9.4.14.1. Overview
      • 9.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.14.3. Technology Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. Agilent Technologies, Inc
      • 9.4.15.1. Overview
      • 9.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.15.3. Technology Benchmarking
      • 9.4.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global tissue diagnostics market, by region, 2018 - 2030 (USD Billion)
  • Table 3 Global tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 4 Global tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 5 Global tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 6 Global tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 7 North America tissue diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 8 North America tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 9 North America tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 10 North America tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 11 North America tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 12 U.S. tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 13 U.S. tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 14 U.S. tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 15 U.S. tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 16 Canada tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 17 Canada tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 18 Canada tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 19 Canada tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 20 Mexico tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 21 Mexico tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 22 Mexico tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 23 Mexico tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 24 Europe tissue diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 25 Europe tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 26 Europe tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 27 Europe tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 28 Europe tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 29 UK tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 30 UK tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 31 UK tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 32 UK tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 33 Germany tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 34 Germany tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 35 Germany tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 36 Germany tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 37 France tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 38 France tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 39 France tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 40 France tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 41 Italy tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 42 Italy tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 43 Italy tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 44 Italy tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 45 Spain tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 46 Spain tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 47 Spain tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 48 Spain tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 49 Denmark tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 50 Denmark tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 51 Denmark tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 52 Denmark tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 53 Sweden tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 54 Sweden tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 55 Sweden tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 56 Sweden tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 57 Norway tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 58 Norway tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 59 Norway tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 60 Norway tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 61 Asia Pacific tissue diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 62 Asia Pacific tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 63 Asia Pacific tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 64 Asia Pacific tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 65 Asia Pacific tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 66 Japan tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 67 Japan tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 68 Japan tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 69 Japan tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 70 China tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 71 China tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 72 China tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 73 China tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 74 India tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 75 India tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 76 India tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 77 India tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 78 Australia tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 79 Australia tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 80 Australia tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 81 Australia tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 82 South Korea tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 83 South Korea tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 84 South Korea tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 85 South Korea tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 86 Thailand tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 87 Thailand tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 88 Thailand tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 89 Thailand tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 90 Latin America tissue diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 91 Latin America tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 92 Latin America tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 93 Latin America tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 94 Latin America tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 95 Brazil tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 96 Brazil tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 97 Brazil tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 98 Brazil tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 99 Argentina tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 100 Argentina tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 101 Argentina tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 102 Argentina tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 103 MEA tissue diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 104 MEA tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 105 MEA tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 106 MEA tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 107 MEA tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 108 South Africa tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 109 South Africa tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 110 South Africa tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 111 South Africa tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 112 Saudi Arabia tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 113 Saudi Arabia tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 114 Saudi Arabia tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 115 Saudi Arabia tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 116 UAE tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 117 UAE tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 118 UAE tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 119 UAE tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)
  • Table 120 Kuwait tissue diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 121 Kuwait tissue diagnostics market, by modality, 2018 - 2030 (USD Billion)
  • Table 122 Kuwait tissue diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 123 Kuwait tissue diagnostics market, by end use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Tissue diagnostics testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Technology and end use snapshot
  • Fig. 11 Application and modality Segment snapshot
  • Fig. 12 Competitive landscape snapshot
  • Fig. 13 In Vitro Diagnostics (IVD) market value, 2023 (USD billion)
  • Fig. 14 Market trends & outlook
  • Fig. 15 Incidence of most common cancers globally, 2022
  • Fig. 16 Incidence of most common cancers region wise, 2022
  • Fig. 17 FDA approved Companion Diagnostic (CDx) assays as of 2020
  • Fig. 18 Consultant workforce retiring in the next 5 years across all specialties, 2021-2024
  • Fig. 19 Porter's five force analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Tissue diagnostics market: Technology outlook and key takeaways
  • Fig. 22 Tissue diagnostics market: Technology movement analysis
  • Fig. 23 Immunohistochemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Slide staining system market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Tissue microarrays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Tissue processing systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Slide scanners market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Cell processors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Microtomes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Embedding systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Cover slippers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Other products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 H&E stainer coverslipper market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 IHC stainer coverslipper market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Other IHC reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 In situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Stainers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Primary & special staining market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Digital pathology and workflow market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Image analysis informatics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Information management system storage & communication market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Anatomic pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Microtomes & cryostat microtomes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Tissue processors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Automatic strainers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Microscopes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Other products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Reagents & antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Probes & kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Molecular pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Fluorescence reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Tissue diagnostics market: Application outlook and key takeaways
  • Fig. 68 Tissue diagnostics market: Application movement analysis
  • Fig. 69 Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Non-small cell lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Gastric cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Other cancers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Tissue diagnostics market: End Use outlook and key takeaways
  • Fig. 75 Tissue diagnostics market: End Use movement analysis
  • Fig. 76 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Diagnostic center market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Pharmaceutical organizations market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 CRO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Tissue diagnostics market: Modality outlook and key takeaways
  • Fig. 81 Tissue diagnostics market: Modality movement analysis
  • Fig. 82 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Pharma/CRO/Research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Tissue diagnostics market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 85 Regional marketplace: Key takeaways
  • Fig. 86 Regional marketplace: Key takeaways
  • Fig. 87 North America tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 U.S. tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Canada tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Mexico tissue diagnostics market estimates and forecast, 2018-2030 (USD Million)
  • Fig. 94 Europe tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 UK tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Germany Tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 France tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Spain tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Italy Tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 Denmark tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Sweden tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 Norway tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Rest of Europe tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Asia Pacific tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 Japan tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 China tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 117 Key country dynamics
  • Fig. 118 India tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 119 Key country dynamics
  • Fig. 120 Australia tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 121 Key country dynamics
  • Fig. 122 Thailand tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 123 Key country dynamics
  • Fig. 124 South Korea tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Rest of Asia Pacific tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 126 Latin America tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Key country dynamics
  • Fig. 128 Brazil tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 129 Key country dynamics
  • Fig. 130 Argentina tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 131 Rest of Latin America tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 132 MEA tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 133 Key country dynamics
  • Fig. 134 South Africa tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 135 Key country dynamics
  • Fig. 136 Saudi Arabia tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 137 Key country dynamics
  • Fig. 138 UAE tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 139 Key country dynamics
  • Fig. 140 Kuwait tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 141 Rest of MEA tissue diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 142 Key company categorization
  • Fig. 143 Company market share analysis, 2023
  • Fig. 144 Strategic framework